Some people tolerate one medication better than another
Research on GLP-1s shows dose-dependent outcomes, with higher studied doses generally producing greater average results
As illustrated above, our algorithm for product innovation focuses on identifying indications that have an unmet medical need, have a clinically validated parent drug or pathway, are suitable to our TransCon technologies, have potential for creating a clearly differentiated product, have a potential established development pathway, and have the potential to address a large market
Hink et al
Author International Federation of Health Plans
Trizomal Glutathione is a comprehensive approach to supporting overall glutathione levels and, thus, total body antioxidant capacity.* It not only includes bioactive glutathione (GSH), all in unique liposomal vessels.